- Home
- LSB vs MIRA Comparison
LSB vs MIRA Comparison
Compare LSB & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSB
- MIRA
- Stock Information
- Founded
- LSB 2002
- MIRA 2020
- Country
- LSB China
- MIRA United States
- Employees
- LSB N/A
- MIRA N/A
- Industry
- LSB
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- LSB
- MIRA Health Care
- Exchange
- LSB NYSE
- MIRA Nasdaq
- Market Cap
- LSB 22.3M
- MIRA 19.5M
- IPO Year
- LSB N/A
- MIRA 2023
- Fundamental
- Price
- LSB $1.00
- MIRA $1.21
- Analyst Decision
- LSB
- MIRA Strong Buy
- Analyst Count
- LSB 0
- MIRA 2
- Target Price
- LSB N/A
- MIRA $14.00
- AVG Volume (30 Days)
- LSB 24.2K
- MIRA 185.1K
- Earning Date
- LSB 07-07-2025
- MIRA 08-12-2025
- Dividend Yield
- LSB N/A
- MIRA N/A
- EPS Growth
- LSB N/A
- MIRA N/A
- EPS
- LSB N/A
- MIRA N/A
- Revenue
- LSB $79,415,311.00
- MIRA N/A
- Revenue This Year
- LSB $39.33
- MIRA N/A
- Revenue Next Year
- LSB $75.61
- MIRA N/A
- P/E Ratio
- LSB N/A
- MIRA N/A
- Revenue Growth
- LSB N/A
- MIRA N/A
- 52 Week Low
- LSB $0.36
- MIRA $0.51
- 52 Week High
- LSB $6.82
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- LSB 37.29
- MIRA 46.79
- Support Level
- LSB $0.91
- MIRA $1.21
- Resistance Level
- LSB $1.03
- MIRA $1.30
- Average True Range (ATR)
- LSB 0.06
- MIRA 0.08
- MACD
- LSB 0.01
- MIRA -0.01
- Stochastic Oscillator
- LSB 43.75
- MIRA 31.58
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.